Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Interact Cardiovasc Thorac Surg ; 24(2): 260-264, 2017 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-27803121

RESUMEN

Objectives: Postoperative atrial fibrillation (POAF) increases morbidity, hospital stay and healthcare expenditure. This study aims to determine the perioperative factors correlating with POAF as well as to evaluate both treatment strategies and AF persistence beyond discharge. Methods: The records of all patients undergoing anatomical lung resection over a 1-year period were retrospectively reviewed. Patients with a history of arrhythmia were excluded. POAF was defined by clinical diagnosis and electrocardiography. Pre- and postoperative demographic and clinical data were collected, and uni- and multivariable regression were performed to determine the factors associated with POAF. Results: POAF occurred in 11.4% (43/377) of patients with a mean of 3.55 days postoperatively and significantly increased hospital stay (6.78 ± 4.42 vs 10.8 ± 5.8 days (P = 0.0014)). No correlation was found with gender, hypertension, ischaemic heart disease, beta-blocker use, alcohol consumption or thyroid dysfunction. However, older age (P = 0.001) and postoperative infection (P < 0.0001; χ2 = 26.03) were found to be significant uni- and multivariable predictors of POAF. Open surgery rather than video assisted thoracoscopic surgery (VATS) (open 26/189 (13.8%); VATS 17/188 (9.0%); P = 0.150) demonstrated a tendency towards increased postoperative AF; however, this was not statistically significant. Four (9.3%) patients remained in AF on discharge, and three required long-term anticoagulation. Three (7%) patients were found to have ongoing AF at 1-month follow-up. Conclusions: Increasing age and postoperative infection are most strongly associated with POAF. Adoption of enhanced recovery protocols, along with more rigorous monitoring and early treatment of postoperative infection may help reduce POAF and its associated morbidity. Rhythm assessment is crucial to identify persistent AF after discharge, and clinicians should be vigilant for recurrence of AF at follow-up.


Asunto(s)
Fibrilación Atrial/epidemiología , Fibrilación Atrial/terapia , Neumonectomía/efectos adversos , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/terapia , Cirugía Torácica Asistida por Video/efectos adversos , Adulto , Anciano , Anciano de 80 o más Años , Fibrilación Atrial/diagnóstico , Electrocardiografía , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Tiempo de Internación , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/diagnóstico , Estudios Retrospectivos , Factores de Riesgo , Reino Unido , Adulto Joven
2.
J Thorac Oncol ; 5(10): 1544-50, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20802350

RESUMEN

INTRODUCTION: To investigate prognostic factors for patient survival after surgical palliation of malignant pleural effusion (MPE). METHOD: We reviewed 278 consecutive nonoverseas patients (108 men, median age: 60 years [range 26-89]) undergoing 310 surgical procedures for palliation of MPE over a 72-month period. There were 195 thoracoscopic talc pleurodesis, 39 pleuroperitoneal shunts, 38 pleurodesis by an intercostal drain, 29 pleural biopsies alone, and nine long-term drains. Referring physicians provided survival data. The significance of prognostic factors was examined with the log-rank test (Kaplan-Meier), those significant entered a Cox logistic multivariate regression analysis. RESULTS: Follow-up was complete until death (following 264 procedures) and for a median 648 days (range 173-2135) for surviving patients. Overall median postoperative survival was 211 days (95% confidence interval: 169-253). Survival was not significantly different for tumor type or method of palliation. In univarate analysis, preoperative leucocytosis, hypoxemia, raised alanine transaminase, body mass index below 18 and hypoalbuminemia were associated with a significantly reduced postoperative survival. In multivariate analysis, leucocytosis (p < 0.0001), hypoxemia (p = 0.014), and hypoalbuminemia (p < 0.0001) maintained significance. CONCLUSIONS: The survival reported demonstrates the necessity of an active approach to palliation of MPE. The identification of prognostic factors will assist the choice of palliative technique. In addition, an appreciation of the influence of selection on survival after surgical palliation of malignant pleural mesothelioma, especially that of unforeseen prognostic factors, is useful when evaluating the results of aggressive treatment such as chemoradiotherapy and radical surgery for these diseases.


Asunto(s)
Neoplasias/mortalidad , Cuidados Paliativos , Derrame Pleural Maligno/mortalidad , Derrame Pleural Maligno/cirugía , Neoplasias Pleurales/mortalidad , Pleurodesia/mortalidad , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Neoplasias/cirugía , Neoplasias Pleurales/cirugía , Pronóstico , Tasa de Supervivencia
6.
Ann Thorac Surg ; 83(1): 314-5, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17184695

RESUMEN

We report a case of malignant pleural mesothelioma with histologically proven spontaneous regression of pleural disease. During a 12-year follow-up there was a single recurrence, which was a lesion in the chest wall at 6 years that was surgically excised. A prominent host response to tumor was seen in both the primary tumor and the recurrence.


Asunto(s)
Mesotelioma/cirugía , Regresión Neoplásica Espontánea , Neoplasias Pleurales/cirugía , Estudios de Seguimiento , Humanos , Masculino , Mesotelioma/mortalidad , Mesotelioma/fisiopatología , Persona de Mediana Edad , Neoplasias Pleurales/mortalidad , Neoplasias Pleurales/fisiopatología
7.
Ann Thorac Surg ; 82(1): 334-6, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16798249

RESUMEN

Abdominal compartment syndrome is an increasingly recognized phenomenon. We report the case of an otherwise fit and healthy 42-year-old man who underwent plication of the right hemidiaphragm for idiopathic phrenic paresis. His postoperative recovery was complicated by abdominal compartment syndrome, which was managed conservatively. We believe this is the only report of this complication after diaphragmatic plication and one of very few reported thoracic causes of abdominal compartment syndrome.


Asunto(s)
Abdomen , Síndromes Compartimentales/etiología , Complicaciones Posoperatorias/etiología , Parálisis Respiratoria/cirugía , Adulto , Alanina Transaminasa/sangre , Aspartato Aminotransferasas/sangre , Síndromes Compartimentales/terapia , Disnea/etiología , Humanos , Intubación Gastrointestinal , Riñón/fisiopatología , Hígado/fisiopatología , Presión Negativa de la Región Corporal Inferior , Masculino , Neuritis/complicaciones , Oliguria/etiología , Nervio Frénico , Espirometría , Técnicas de Sutura
8.
Eur J Cardiothorac Surg ; 27(4): 675-9, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15784373

RESUMEN

OBJECTIVE: Sublobar resections may offer a method of increasing resection rates in patients with lung cancer and poor lung function, but are thought to increase recurrence and therefore compromise survival for stage I non-small cell lung cancer (NSCLC). To test this hypothesis we have compared the long-term outcome from lobectomy and anatomical segmentectomy in high-risk cases as defined by predicted postoperative FEV1 (ppoFEV1) less than 40%. METHODS: Over a 7-year period 55 patients (27% of all resections for stage I NSCLC) with ppoFEV1<40% underwent resection of stage I NSCLC. The 17 patients who underwent anatomical segmentectomy were individually matched to 17 patients operated by lobectomy on the bases of gender, age, use of VATS, tumour location and respiratory function. We compared their perioperative course, tumour recurrence and survival. RESULTS: There were no significant differences in hospital mortality (one case in each group), complications or hospital stay. Overall 5-year survival was 69%. There were no differences in recurrence rates (18% in both groups) or survival (64% after lobectomy and 70% after segmentectomy). There was preservation of pulmonary function after segmentectomy (median gain of 12%) compared to lobectomy (median loss of 12%) (P=0.02). CONCLUSIONS: Anatomical segmentectomy allowed for surgical resection in patients with stage I NSCLC and impaired respiratory reserve without compromising oncological results but with preservation in respiratory function.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/cirugía , Neoplasias Pulmonares/cirugía , Neumonectomía/métodos , Anciano , Anciano de 80 o más Años , Carcinoma de Pulmón de Células no Pequeñas/patología , Métodos Epidemiológicos , Femenino , Volumen Espiratorio Forzado , Humanos , Neoplasias Pulmonares/patología , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Complicaciones Posoperatorias , Recurrencia , Espirometría , Resultado del Tratamiento
9.
Ann Thorac Surg ; 78(1): 245-52, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15223437

RESUMEN

BACKGROUND: We sought to determine whether or not there are differences in disease progression after radical or nonradical (debulking) surgical procedures for malignant pleural mesothelioma. METHODS: Over a 49-month period, 132 patients with malignant pleural mesothelioma underwent surgery. Fifty-three underwent extrapleural pneumonectomy and 79 underwent nonradical procedures. Time to evidence of clinical disease progression was recorded, as was the site(s) of that disease. RESULTS: One-hundred nineteen patients were evaluable, of which 59% (22 radical; 48 nonradical) had disease progression. Overall 30-day mortality was 8.5% (7.5% radical; 9% nonradical). The median time to overall disease progression was considerably longer after extrapleural pneumonectomy than debulking surgery (319 days vs 197 days, p = 0.019), as was the time to local disease progression (631 days vs 218 days, p = 0.0018). There was no preponderance of earlier stage disease in the radical surgery group. There was a trend toward prolonged survival in those undergoing radical surgery, but no significant difference between the groups (497 days vs 324 days, p = 0.079). In those who had extrapleural pneumonectomy, time-to-disease progression significantly decreased with N2 disease compared with N0/1 involvement (197 days vs 358 days, p = 0.02). CONCLUSIONS: Extrapleural pneumonectomy may be preferable to debulking surgery in malignant pleural mesothelioma to delay disease progression and give greater control of local disease. Involvement of N2 nodes is associated with accelerated disease progression and is therefore a contraindication to extrapleural pneumonectomy.


Asunto(s)
Desoxicitidina/análogos & derivados , Mesotelioma/cirugía , Neoplasias Pleurales/cirugía , Neumonectomía/estadística & datos numéricos , Neoplasias Abdominales/secundario , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Cisplatino/administración & dosificación , Terapia Combinada , Contraindicaciones , Desoxicitidina/administración & dosificación , Diafragma/cirugía , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Escisión del Ganglio Linfático , Metástasis Linfática , Masculino , Mesotelioma/clasificación , Mesotelioma/tratamiento farmacológico , Mesotelioma/mortalidad , Mesotelioma/patología , Mesotelioma/radioterapia , Mesotelioma/secundario , Persona de Mediana Edad , Terapia Neoadyuvante , Invasividad Neoplásica , Pericardio/cirugía , Neoplasias Pleurales/tratamiento farmacológico , Neoplasias Pleurales/mortalidad , Neoplasias Pleurales/patología , Neoplasias Pleurales/radioterapia , Neumonectomía/métodos , Pronóstico , Prótesis e Implantes , Radioterapia Adyuvante , Mallas Quirúrgicas , Análisis de Supervivencia , Cirugía Torácica Asistida por Video/estadística & datos numéricos , Resultado del Tratamiento , Gemcitabina
10.
Ann Thorac Surg ; 77(3): 1039-44, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-14992923

RESUMEN

BACKGROUND: There is little objective evidence concerning the outcome of thoracic surgical patients who suffer postoperative complications. We assessed the outcome and cost of care for patients admitted to the intensive care unit after initial recovery from pulmonary resection in a high dependency unit. METHODS: In a single surgeon's practice, over a 3-year period, 28 patients [22 male, median age 66 years old (range 48-80 years old)] required intensive care admission. Preoperative pulmonary function, reason for initial operation, cause of intensive care admission, interventions, and outcome in hospital and at 6 months was studied. The cost of care provided was estimated. RESULTS: The major reason for intensive care admission was respiratory failure; 61% of patients required mechanical ventilation and 54% renal support. All 4 patients who required both mechanical ventilation and hemofiltration died. Intensive care and 6-month survival were 54% and 36%, respectively. On univarate analysis mechanical ventilation and renal support predicted both hospital mortality (p < 0.001 and p = 0.003) and 6-month mortality (p = 0.003 and p = 0.01). Patients who died in intensive care stayed longer (median stay 9 vs 3 days; p = 0.04) at a higher cost per patient (median cost $6975 vs $19,375; p = 0.04) than those who survived. CONCLUSIONS: Patients who suffer complications after lung resection and require salvage intensive care, particularly mechanical ventilation, have a poor prognosis. In the light of this data the onset of two-organ failure should prompt an informed discussion as to whether escalation of treatment is in the patient's best interest.


Asunto(s)
Cuidados Críticos , Neumonectomía , Terapia Recuperativa , Anciano , Anciano de 80 o más Años , Cuidados Críticos/economía , Hemofiltración , Humanos , Masculino , Persona de Mediana Edad , Insuficiencia Multiorgánica , Complicaciones Posoperatorias/mortalidad , Pronóstico , Respiración Artificial , Insuficiencia Respiratoria/terapia , Tasa de Supervivencia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA